This researcher has focused on synthesizing novel heterocyclic compounds and exploring their roles in understanding chiral centers, biological activity, and reactivity. Their work encompasses the development of synthetic frameworks for calpain inhibitors, quinazolines, bisbenzamidines, and dihydrophenoxiamides, which have significant applications in treating conditions such as Alzheimer's disease, Leishmaniasis, and pseudomonas species resistance. The research also investigates the role of these compounds in cognitive function, neurodegenerative diseases, and the impact of anti-Pneumocystis carinii activity in preventing pneumonia. Additionally, their studies highlight the importance of molecular modeling and chiral properties in elucidating the mechanisms behind disease progression and drug efficacy.
All Papers
No collaborations found in the dataset.
This profile is generated from publicly available publication metadata and is intended for research discovery purposes. Themes, summaries, and trajectories are inferred computationally and may not capture the full scope of the lecturer's work. For authoritative information, please refer to the official KNUST profile.